On April 25, Gelonghui Pharmaceutical (600285.SH) released its first quarter report. Operating revenue was 909 million yuan, up 15.27% year on year, net profit of 190 million yuan, up 31.98% year on year, after deducting non-net profit of 181 million yuan, up 31.55% year on year, with basic earnings of 0.340 yuan per share.
羚锐制药(600285.SH)：一季度净利润1.9亿元 同比增长31.98%
Ling Rui Pharmaceutical (600285.SH): Net profit of 190 million yuan in the first quarter increased by 31.98% year-on-year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.